Edesa Biotech EDSA
NASDAQ EDSA
$2.85 +0.03 (+1.06%)
At close: Oct 21, 2026 · 4:00 PM EDT

Edesa Biotech (EDSA) Debt Ratio (2021 - 2022)

Updated

Edesa Biotech's Debt Ratio came in at 0.00 for fiscal Q4 2022 (quarter ended Sep 30, 2022), up 16.5% from 0.00 a year earlier.

Analysis

Edesa Biotech (EDSA) Debt Ratio (2021 - 2022) Analysis & Trends

  • Going back by fiscal year, Debt Ratio was 0.00 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.39
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.24
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.52
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.42
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.08
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.28
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.60
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.53
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 Edesa Biotech 26.08 Mn -19.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 0.00
Sep 30, 2021 0.00
API Access

Edesa Biotech Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=EDSA&period=max&api_key=YOUR_API_KEY